TY  - GEN
AU  - Mason,John O
AU  - Frederick,Paul A
AU  - Neimkin,Michael G
AU  - White,Milton F
AU  - Feist,Richard M
AU  - Thomley,Martin L
AU  - Albert,Michael A
TI  - Incidence of hemorrhagic complications after intravitreal bevacizumab (avastin) or ranibizumab (lucentis) injections on systemically anticoagulated patients
SN  - 1539-2864
PY  - 2010///1217
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - administration & dosage
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Anticoagulants
KW  - Aspirin
KW  - Bevacizumab
KW  - Choroidal Neovascularization
KW  - drug therapy
KW  - Clopidogrel
KW  - Eye Hemorrhage
KW  - epidemiology
KW  - Female
KW  - Humans
KW  - Incidence
KW  - Intravitreal Injections
KW  - Macular Degeneration
KW  - Male
KW  - Middle Aged
KW  - Platelet Aggregation Inhibitors
KW  - Ranibizumab
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Ticlopidine
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - Warfarin
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/IAE.0b013e3181e09739
ER  -